Redmile Group, LLC Atri Cure, Inc. Transaction History

Redmile Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $8.73 Million - $9.99 Million	-325,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $659,500 - $833,500	25,000 Added 8.33%	325,000 $8.71 Million
Q4 2018 Feb 14, 2019	BUY	$26.66 - $34.85 $8 Million - $10.5 Million	300,000 New	300,000 $9.18 Million

229

47.1M

25.8K

4.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.56B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.